Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-001245
Filing Date
2020-01-15
Accepted
2020-01-15 16:40:21
Documents
1
Period of Report
2020-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4055
  Complete submission text file 0000899243-20-001245.txt   5389
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-780-6356
Viela Bio, Inc. (Issuer) CIK: 0001734517 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEDIMMUNE WAY FLOOR ONE, AREA TWO GAITHERSBURG MD 20879
Business Address
Kastenmayer James Paul (Reporting) CIK: 0001798800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39067 | Film No.: 20528649